93076-98-3

93076-98-3 structure
93076-98-3 structure
  • Name: R 59-022 hydrochloride
  • Chemical Name: R 59-022 hydrochloride
  • CAS Number: 93076-98-3
  • Molecular Formula: C27H27ClFN3OS
  • Molecular Weight: 496.04
  • Catalog: Signaling Pathways Epigenetics PKC
  • Create Date: 2023-04-04 15:46:49
  • Modify Date: 2024-04-02 18:09:59
  • R 59-022 (DKGI-I) hydrochloride is a DGK inhibitor (IC50: 2.8 µM). R 59-022 hydrochloride inhibits the phosphorylation of OAG to OAPA. R 59-022 hydrochloride is a 5-HT Receptor antagonist, and activates protein kinase C (PKC). R 59-022 hydrochloride potentiates thrombin-induced diacylglycerol production in platelets and inhibits phosphatidic acid production in neutrophils[1][2][3][4].

Name R 59-022 hydrochloride
Description R 59-022 (DKGI-I) hydrochloride is a DGK inhibitor (IC50: 2.8 µM). R 59-022 hydrochloride inhibits the phosphorylation of OAG to OAPA. R 59-022 hydrochloride is a 5-HT Receptor antagonist, and activates protein kinase C (PKC). R 59-022 hydrochloride potentiates thrombin-induced diacylglycerol production in platelets and inhibits phosphatidic acid production in neutrophils[1][2][3][4].
Related Catalog
Target

PKC

serotonin

DGK:2.8 μM (IC50)

In Vitro R 59-022 (10 μM,1 分钟) hydrochloride 增强血小板聚集[2]。 R 59-022 (30 μM,0-60 分钟) hydrochloride 增加嗜铬细胞中去甲肾上腺素的释放[3]。 R 59-022 (40 μM,30 分钟) hydrochloride 激活 HeLa 和 U87 细胞中的 PKC[4]。 R 59-022 (0-10 μM,4 小时) hydrochloride 阻断 EBOV GP 进入 Vero 细胞[5]。 Western Blot Analysis[4] Cell Line: HeLa cells Concentration: 40 uM Incubation Time: 30 min Result: Increased the phosphorylation of PKC downstream targets by about 2.5-fold.
In Vivo R 59-022 (2 mg/kg,腹腔注射,12 天) hydrochloride 显着增加植入 U87 GBM 细胞的 SCID 小鼠的中位生存期[6]。 Animal Model: SCID mice implanted with U87 GBM cells[6] Dosage: 10 mg/kg Administration: Intraperitoneal injection (i.p.) Result: Increased median survival and decreased tumor volume.
References

[1]. de Chaffoy de Courcelles, D.C., et al. R 59 022, a diacylglycerol kinase inhibitor. Its effect on diacylglycerol and thrombin-induced C kinase activation in the intact platelet. J. Biol. Chem. 260(29), 15762-15770 (1985).  

[2]. Nunn DL, et al. A diacylglycerol kinase inhibitor, R59022, potentiates secretion by and aggregation of thrombin-stimulated human platelets. Biochem J. 1987 May 1;243(3):809-13.  

[3]. Jones JA, et al. Influence of phorbol esters, and diacylglycerol kinase and lipase inhibitors on noradrenalinerelease and phosphoinositide hydrolysis in chromaffin cells. Br J Pharmacol. 1990 Nov;101(3):521-6.  

[4]. Boroda S, et al. Dual activities of ritanserin and R59022 as DGKα inhibitors and serotonin receptor antagonists. Biochem Pharmacol. 2017 Jan 1;123:29-39.  

[5]. Stewart CM, et al. A Diacylglycerol Kinase Inhibitor, R-59-022, Blocks Filovirus Internalization in Host Cells. Viruses. 2019 Mar 1;11(3). pii: E206.  

[6]. Dominguez CL, et al. Diacylglycerol kinase α is a critical signaling node and novel therapeutic target in glioblastoma and other cancers. Cancer Discov. 2013 Jul;3(7):782-97.  

Molecular Formula C27H27ClFN3OS
Molecular Weight 496.04
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.